IFNG and cancer: To further characterize the findings, we obtained the interferon-stimulated gene resistance signature (ISG.RS) and the Interferon-gamma hallmark gene set (IFNG.GS) from the published literature [24], in which IFNG.GS is predominantly expressed by intratumoral immune cells, leading to T cell depletion, and ISG.RS is predominantly expressed in cancer cells.